Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis. Bright HRB, Smith CH, Laws P, Reynolds NJ, et al. Br J Dermatol 2026 Apr 30:ljag170. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bright HRB, Smith CH, Laws P, Reynolds NJ, et al. Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis. Br J Dermatol 2026 Apr 30:ljag170. doi: 10.1093.
PMID: 42056008